Diasorin Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 47.00 Cr
as on 27-07-2024
- Paid Up Capital ₹ 47.00 Cr
as on 27-07-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.00 Cr
as on 27-07-2024
- Revenue -2.81%
(FY 2023)
- Profit -96.49%
(FY 2023)
- Ebitda -53.86%
(FY 2023)
- Net Worth 0.83%
(FY 2023)
- Total Assets 10.93%
(FY 2023)
About Diasorin Healthcare India
The Corporate was formerly known as Diasorin Trivitron Healthcare Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 47.00 Cr and a paid-up capital of Rs 47.00 Cr.
The company has closed loans amounting to ₹7.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Diasorin Healthcare India Private Limited India is Vaibhav Gandhi as COMPANY SECRETARY. John Hoffarth, Joshua Glason, Valerio Vaccarone, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100MH2012FTC323879
- Company No.
323879
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
10 Jul 2012
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Andheri East, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Diasorin Healthcare India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaibhav Gandhi | Company Secretary | 04-Mar-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
John Hoffarth  | Director | 29-Jun-2020 | Current |
Joshua Glason  | Director | 02-Mar-2023 | Current |
Valerio Vaccarone  | Director | 02-Mar-2023 | Current |
Prem Charles  | Additional Director | 20-Jun-2024 | Current |
Financial Performance and Corporate Structure Insights of Diasorin Healthcare India.
Diasorin Healthcare India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.81% decrease. The company also saw a substantial fall in profitability, with a 96.49% decrease in profit. The company's net worth moved up by a moderate rise of 0.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diasorin Healthcare India?
In 2023, Diasorin Healthcare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Aug 2016 | ₹4.00 Cr | Satisfied |
Rbl Bank Limited Creation Date: 24 Feb 2014 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Diasorin Healthcare India?
Diasorin Healthcare India has a workforce of 30 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diasorin Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diasorin Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
